![]() |
|
|
Vol. 282, Issue 1, 467-474, 1997
-carbomethoxy-3
-(3
,4
-dichlorophenyl)nortropane
(
-CDIT), a Tropane Derivative: Pharmacological Characterization as a
Specific Ligand for the Dopamine Transporter in the Rodent
Brain1
INSERM U316, Laboratoire de Biophysique Médicale et
Pharmaceutique, 37200 Tours, France (L.G., P.E., D.G., Y.F., J.-C.B.,
S.C.), and
Laboratoire d'Ethologie et de Pharmacologie du
Comportement, Faculté des Sciences, 37200 Tours, France (C.B.)
N-(3-Iodoprop-2E-enyl)-2
-carbomethoxy-3
-(3
,4
-dichlorophenyl)nortropane
(
-CDIT), a new iodinated tropane derivative, has been synthesized
and radiolabeled with iodine. [125I]
-CDIT was tested
in vitro and ex vivo as a probe for the
dopamine transporter site in the rat brain, and behavioral studies were performed in mice. Saturation studies in the striatum revealed that
[125I]
-CDIT bound to a single high-affinity site. The
Kd value was 0.18 ± 0.07 nM, and the corresponding Bmax value was 500 ± 80 fmol/mg of protein. The pharmacological profile of
specific [125I]
-CDIT binding in the striatum
was consistent with that of the dopamine transporter. In addition,
competition studies in cerebral cortex regions with
[3H]paroxetine and [3H]nisoxetine showed a
very low affinity of
-CDIT for the 5-hydroxytryptamine (Ki = 50 nM) and norepinephrine
(Ki = 500 nM) transporters compared with
-CIT (corresponding Ki values
were 3 and 80 nM). In contrast, the competition of
-CDIT with
[3H]GBR 12935 in the striatal region
(Ki = 29 nM) was of the same order of
value as for
-CIT (Ki = 27.5 nM).
Behavioral experiments in mice showed that both
-CDIT and
-CIT
induced stimulation of locomotor activity. Ex vivo
autoradiographic studies in rats using [125I]
-CDIT
demonstrated high densities of [125I]
-CDIT binding
sites in areas known to be rich in dopaminergic innervation. Because of
its high affinity and high selectivity for the dopamine transporter,
[125I]
-CDIT should be a valuable ligand for the
exploration of the dopamine transporter with single-photon emission
computed tomography.
This article has been cited by other articles:
![]() |
S. Chalon, L. Garreau, P. Emond, L. Zimmer, M.-P. Vilar, J.-C. Besnard, and D. Guilloteau Pharmacological Characterization of (E)-N-(3-iodoprop-2-enyl)-2beta -Carbomethoxy-3beta -(4'-methylphenyl)nortropane as a Selective and Potent Inhibitor of the Neuronal Dopamine Transporter J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 648 - 654. [Abstract] [Full Text] |
||||